←Back to Expert Scholars
Translational Medicine / 转化医学Arginase in Tumor Microenvironment
Paul Blau
MD
🏢NYU Langone Health Perlmutter Cancer Center🌐USA
Associate Professor of Medicine
30
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Paul Blau investigates arginase dependent immunosuppression by myeloid cells in the tumor microenvironment. His laboratory has tested arginase inhibitors in combination with checkpoint blockade in preclinical models. He leads early phase immunotherapy combination trials at NYU.
Share:
🧪Research Fields 研究领域
arginase
myeloid derived suppressor cells
tumor microenvironment
immunotherapy combinations
small molecule inhibitors
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Paul Blau 的研究动态
Follow Paul Blau's research updates
留下邮箱，当我们发布与 Paul Blau（NYU Langone Health Perlmutter Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment